Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 8, 2019 Off

Moderna Reports First Quarter 2019 Financial Results and Provides Business Updates

By BusinessWire

Rare Diseases: New development candidate announced for glycogen storage disease type 1a (GSD1a), a rare metabolic disorder; Company now has…

May 8, 2019 Off

McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results

By BusinessWire

Fourth-quarter fiscal 2019 revenues of $52.4 billion and full-year fiscal 2019 revenues of $214.3 billion, a full-year increase of 3%.…

May 8, 2019 Off

BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio

By BusinessWire

MAINZ, Germany–(BUSINESS WIRE)–BioNTech SE, a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious…

May 8, 2019 Off

ReForm Biologics Announces Issuance of U.S. Patent on Stabilizing Excipients for Therapeutic Protein Formulations

By BusinessWire

New class of excipients offers a promising alternative to polysorbates for stabilizing proteins WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, a pharmaceutical technology…

May 8, 2019 Off

GVK BIO Announces the Appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.

By BusinessWire

HYDERABAD, India & MORGAN HILL, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Antibodydiscovery?src=hash" target="_blank"gt;#Antibodydiscoverylt;/agt;–GVK BIO is pleased to announce the appointment of Dr. Axel Schleyer…

May 8, 2019 Off

Gilead Sciences and Goldfinch Bio Announce Strategic Collaboration to Develop Novel Therapies for Kidney Disease

By BusinessWire

— Companies to Pursue a Human Genetics Approach to Drug Discovery and Development — FOSTER CITY, Calif. & CAMBRIDGE, Mass.–(BUSINESS…

May 8, 2019 Off

Rocket Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights

By BusinessWire

– Initiated Phase 1 Trial for FA “Process B” Using a Modified Cell Enrichment Process, Transduction Enhancers, and Commercial-Grade Vector…

May 8, 2019 Off

Acerus Approved to Trade on the OTCQB Venture Market under the Symbol ASPCF

By BusinessWire

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR…

May 8, 2019 Off

Global Vitamin D Therapy Market Forecasts to 2024 – Lucrative Opportunities in Countries with a High Prevalence of Under-Nutrition – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Vitamin D Therapy Market by Route of administration, Age Group, Purchase Pattern, Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin…

May 8, 2019 Off

Pfizer Acquires Clinical-Stage Biotech Therachon

By BusinessWire

Expands Pfizer’s rare disease portfolio with potential first-in-class therapy for achondroplasia, a genetic condition and the most common form of…

Posts pagination

Previous 1 … 3,215 3,216 3,217 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine